Macrocytosis without anaemia (isolated raised MCV)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
MCV > 100 fL without anaemia: first-line tests
Laboratory tests
- Repeat FBC with blood film examination (macro-ovalocytes, hypersegmented neutrophils)
- Reticulocyte count
- Vitamin B12
- GGT (if alcohol consumption possible)if needednon-French guidelineAlcohol is the leading cause of macrocytosis in ambulatory care; in macrocytic patients, the screening questionnaire and GGT are the two most sensitive tests for detecting alcohol misuse [1].
- Carbohydrate-deficient transferrin (CDT) (if alcohol consumption uncertain or disputed)if neededAlcohol consumption denied or uncertain, to discuss it with an ambivalent patient: CDT rises after at least 10 days at 60 g of alcohol a day or more, has a specificity of 80 to 90% (better than GGT) and a half-life of about 15 days; combined with GGT, its sensitivity rises to 80% [2].
Also consider
First-line tests not informative
Laboratory tests
- TSH
- AST
- ALT
- GGT
- Serum creatinine with eGFR
- Red cell folate (if no other cause is found)if needednon-French guidelineRed cell folate reflects stores better than serum folate; to be requested if no other cause is found [1].
- Methylmalonic acid (if B12 in the indeterminate range; not reimbursed in France)if needednon-French guidelineB12 between 180 and 350 ng/L with symptoms or signs of deficiency: methylmalonic acid helps to decide [3]. See the page “Low vitamin B12”.
Also consider
- Other associated cytopenia? An associated neutropenia or thrombocytopenia moves to the page “Bicytopenia or pancytopenia”.
Do not order
- Serum folate: it fluctuates rapidly with intake and is of little use; prefer red cell folate [1].
Sources (14)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8.
- Société française d'alcoologie. Mésusage de l'alcool : dépistage, diagnostic et traitement. Recommandation de bonne pratique (méthode RPC), 9 février 2015, actualisée le 5 juin 2023 : annexe 2 « Examens biologiques et mésusage d'alcool ».
- National Institute for Health and Care Excellence. Vitamin B12 deficiency in over 16s: diagnosis and management. NICE guideline NG239, 6 mars 2024.
- NHS Lothian. RefHelp, Haematology : Macrocytosis (isolated). Guide d'orientation pour les médecins généralistes, publié le 3 mai 2022, mis à jour le 24 juillet 2026.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1387 (folates sériques ou érythrocytaires).
- Hofmann WK, Platzbecker U, Sockel K, Götze K, Haase D, Thol F, Stauder R, Passweg J, Germing U. Myelodysplastische Neoplasien (Myelodysplastische Syndrome, MDS). Leitlinie Onkopedia (DGHO, OeGHO, SGMO, SSH), Stand März 2026.
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Base de données publique des médicaments. VALPROATE DE SODIUM ARROW L.P. 500 mg, résumé des caractéristiques du produit, rubrique 4.8 (CIS 69386390).
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)
- Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203-8. (médicaments)